Abstract
To investigate effect of poly (ADP-ribose) polymerase inhibition on the proliferation of CT26 cells in vitro and the mechanism of this effect. CT26 cells were treated with a range of concentrations of 5-Aminoisoquinolin-1-one (PARP inhibitor) in vitro. MTT assays and flow cytometry were used to determine the proliferation and cell cycle distribution, respectively, of the cells. The expression of PARP-1 was investigated by Western blot. The binding of Nuclear Factor-κB to DNA was detected by electrophoretic mobility shift assay. The proliferation of CT26 cells was significantly inhibited by 5-AIQ induced PARP inhibition in a dose-dependent manner. Proliferation was inhibited by 17.5% at 100 μM 5-AIQ, by 27.6% at 500 μM 5-AIQ and by 39.9% at 1000 μM (P < 0.05). After treatment with 5-AIQ, the proportion of cells in G0/Gl phases increased and the proportion of cells in S phase decreased. The expression of PARP-1 was attenuated in 5-AIQ-treated CT26 cells (P < 0.05) and the binding of NF-κB to DNA binding was similarly diminished (P < 0.05). These results suggest that PARP inhibition reduced the proliferation of CT26 cells in vitro and influences the cell cycle. This inhibition is mediated by inhibiting PARP-1, which then diminishes the activity of NF-κB.
Similar content being viewed by others
Abbreviations
- PARP:
-
Poly (ADP-ribose)polymerase
- 5-AIQ:
-
5-Aminoisoquinolin-1-one
- NF-κB:
-
Nuclear Factor-κB
- ICAM-1:
-
intercellular adhesion molecule-1
References
Cuzzocrea S, Mazzon E, Di Paola R et al (2004) 5-Aminoisoquinolinone reduces colon injury by experimental colitis. Naunyn Schmiedebergs Arch Pharmacol 370:464–473
Mota-Filipe H, Sepodes B, McDonald MC et al (2002) The novel PARP inhibitor 5-aminoisoquinolinone reduces the liver injury caused by ischemia and reperfusion in the rat. Med Sci Monit 8:BR444–453
Cuzzocrea S, McDonald MC, Mazzon E et al (2002) Effects of 5-aminoisoquinolin-one, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase, in a rodent model of lung injury. Biochem Pharmacol 63:293–304
Nosho K, Yamamoto H, Mikami M et al (2006) Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis. Eur J Cancer 42:2374–81
Lockett KL, Hall MC, Xu J (2004) The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res 64:6344–6348
Albert JM, Cao C, Kim KW et al (2007) Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models. Clin. Cancer Res. 13:3033–3042
Kang YH, Yi MJ, Kim MJ et al (2004) caspase-independent cell death by arsenic trioxide in human cervical cancer cells: reactive oxygen species-mediated poly(ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria. Cancer Res. 64:8960–8967
Hao LX, Wang YL, Li YY (2006) Correlation of PARP expression with P-selectin and ICAM-1 expression in colorectal carcinoma. Basic Med Sci Clinics 26:882–887
Woon ECY, Threadgill MD (2005) Poly(ADP-ribose)polymerase inhibition–Where now? Current Med Chem 12:2373–2392
Rajesh M, Mukhopadhyay P, Godlewski G et al (2006) Poly(ADP-ribose)polymerase inhibition decreases angiogenesis. Biochem Biophys Res Commun 350:1056–1062
McDonald MC, Mota-Filipe H, Wright JA et al (2000) Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase on the organ injury and dysfunction caused by haemorrhagic shock. Br J Pharmacol 130:843–850
Zor T, Selinger Z (1996) Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies. Anal Biochem 236:302–308
Ding HL, Li F, Xu MT et al (2002) The effect of inhibiting nuclear factor-kappa B on the diabetic nephropathy. Chinese J Intern Med 41:605–609
Lu JP, Sun H, Cao C et al (2004) InfIuence of nuclear factor˜κB decoy transfection on nuclear factor˜κB activity and vascular endothelial growth factor/urokinase-type plasminogen activator/intercellular cell adhesion molecule-1 level of SKOV3 cells. Chinese J Obstet Gvneco 39:533–537
Genovese T, Mazzon E, Muià C et al (2005) Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma. J Pharmacol Exp Ther 312:449–457
Hao LX, Wang YL, Cai L et al (2007) Inhibitory effect of 5-aminoisoquinolinone on PARP activity in colon carcinoma cell line HT-29. Chinese J Cancer 26:566–571
Nakajima H, Nagaso H, Kakui N et al (2004) Critical role of the automodification of poly(ADP-ribose) polymerase-1 in nuclear factor-κB-dependent gene expression in primary cultured mouse glial cells. J Biol Chem 279:42774–42786
Yu LL, Yu HG, Yu JP et al (2004) Nuclear factor-κB regulates cyclooxygenase-2 expression and cell proliferation in human colorectal carcinoma tissue. Eksp Onkol 26:40–47
Greten FR, Eckmann L, Greten TF et al (2004) IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cel1 118:285–296
Kitamura T, Sekimata M, Kikuchi SI et al (2005) Involvement of poly(ADP-ribose)polymerase 1 in ERBB2 expression in rheumatoid synovial cells. Am J Physiol Cell Physsiol 289:C82–C83
Wu B, Shi D, Yang GK et al (2004) Expression of nuclear factor-κB, C-myc and ICAM -1 in human colorectal cancer and its significance. Chinese J Clin Oncol Rehabilitation 11:102–111
Author information
Authors and Affiliations
Corresponding author
Additional information
Grants support
This work was supported in part by grant from the National Nature Science Foundation of China (NSFC: 30870946) and from Nature Science Foundation Project of Chongqing (CSTC: 2006BB5288)
Rights and permissions
About this article
Cite this article
Cai, L., Threadgill, M.D., Wang, Y. et al. Effect of Poly (ADP-ribose) Polymerase-1 Inhibition on the Proliferation of Murine Colon Carcinoma CT26 Cells. Pathol. Oncol. Res. 15, 323–328 (2009). https://doi.org/10.1007/s12253-008-9116-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-008-9116-y